Last reviewed · How we verify
cefuroxime and metronidazole
At a glance
| Generic name | cefuroxime and metronidazole |
|---|---|
| Sponsor | Halmstad County Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) (PHASE4)
- Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis. (NA)
- Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population
- Reducing the Incidence of Incisional Hernia After Stoma Closure Using a Prophylactic Mesh (NA)
- Role of Delay and Antibiotics on Perforation Rate While Waiting Appendectomy (PHASE4)
- The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial (NA)
- Short-Term Use of Antibiotics and Adherence Level (NA)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cefuroxime and metronidazole CI brief — competitive landscape report
- cefuroxime and metronidazole updates RSS · CI watch RSS
- Halmstad County Hospital portfolio CI